Promising Cleveland Clinic spinoff goes on "hiatus"

CSF Therapeutics, a traumatic brain injury and stroke treatment company spun out from Cleveland Clinic, has shut down. CSF was testing a device designed to maintain blood flow to the brain in patients experiencing a buildup of excess cerebral spinal fluid due to trauma from a stroke or head injury, according to MedCity News. The company has no operations and no employees, according to a Cleveland Clinic spokesman.

CSF was started in late 2006 to much fanfare. "We've spent a lot of time looking at neuro companies and research, and we're excited by this one because it's establishing a new field in neuroscience. Neurodegenerative disorders affect millions of people worldwide and represent a vast area of unmet therapeutic need," Aaron Sandoski, managing director of Norwich Ventures, said at the time. Norwich Ventures had invested $4 million in the company, MD+DI noted.

As MedCity News reports, it's not clear why the company is on hiatus. However, a Cleveland Clinic spokesperson told the news service in an email, "Board decided that additional proof of concept/research needed to be done prior to additional commercialization." Information about CSF has been removed from the Cleveland Clinic spinoff web page.

- get more from MedCity News

Suggested Articles

The clinical testing giant LabCorp will now begin rolling out a blood test for lung cancer developed by Resolution Bioscience.

Cognoa aims to equip pediatricians with an AI-powered app that can spot the signs of autism, allowing them to diagnose in the doctor's office.

Longitude Capital invests in what its founders call “transformative healthcare companies," working in areas they hope will increase quality of life.